LINC-PINT and colon adenocarcinoma: COAD cases exhibiting higher expression of LINC-PINT had significantly lower immune scores, including stromal, immune, and ESTIMATE scores (Figure 1D), meaning that patients with low expression of LINC-PINT have a better immune response.